Key result
The incidence of congenital heart disease at a tertiary referral hospital in Jordan was 17.8 per 1,000 live births, which increased to 24.6 per 1,000 when including patent ductus arteriosus in preterm infants.
Why the study?
Relatively little is known about the epidemiology of congenital heart disease in Jordan or how it is identified.
Observational (n=43,420)
No
The study highlights a high incidence of congenital heart disease in Jordan (17.8 per 1,000 live births) and suggests a need for increased prenatal and perinatal screening.
High postnatal CHD detection with low prenatal diagnosis in Jordan; leaves open whether expanded perinatal screening improves outcomes.
Background Congenital heart disease (CHD) is the most common birth defect and accounts for significant global morbidity and mortality. Relatively little is known about the epidemiology of CHD in Jordan or the manner in which CHD is identified. Methods A retrospective medical record review was conducted for all neonates who had an abnormal echocardiogram performed at a tertiary referral hospital. All included neonates had echocardiography performed by the same pediatric cardiologist at the discretion of the treatment team. Descriptive statistics were used to describe CHD incidence, types of CHD identified, and mechanism of identification. Results The incidence of congenital heart disease was 17.8 per 1,000 live births. This rose to 24.6 per 1,000 if patent ductus arteriosus in preterm infants was included. The most common identified abnormalities were PDA, atrial septal defects, persistent pulmonary hypertension, septal hypertrophy, and ventricular septal defects. Most children were evaluated either for a murmur heard on exam or as a part of screening due to other comorbidities or risk factors. Less than 1% of children had a prenatal diagnosis. There was a higher rate of persistent pulmonary hypertension during the COVID-19 pandemic than before (p < 0.001). Conclusions There is a high incidence of CHD in Jordan. Increased prenatal and perinatal screening for CHD may allow for earlier detection.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2023) conducted an observational in Congenital heart disease (n=43,420). Congenital heart disease was evaluated on Incidence of congenital heart disease (excluding preterm patent ductus arteriosus). The incidence of congenital heart disease at a tertiary referral hospital in Jordan was 17.8 per 1,000 live births, which increased to 24.6 per 1,000 when including patent ductus arteriosus in preterm infants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: